Pemetrexed plus tarceva as salvage treatment in EGFR overexpressed metastatic colorectal cancer patients who were failed after standard chemotherapy: A phase II single arm prospective study

ABSTRACT: Interventions: Drug : Petrexed 500 mg/m2 IV Q 3 weeks + Tarceva 100mg once daily, continous Primary outcome(s): Overall Response Rate

DISEASE(S): Neoplasms

PROVIDER: 2511765 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR